Clover Health officer proposes $110K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clover Health Investments, Corp. (CLOV) officer Joseph Clay Thornton filed notice of a proposed sale of 22,099 Class A common shares, with an aggregate market value of $109,831.46 and an approximate sale date of November 16, 2026. The notice says the proposed sale would cover tax withholding obligations connected with restricted stock unit vesting and settlement through a “sell to cover” transaction, and is not discretionary. It lists March 2, 2026, as the plan adoption or instruction date if relying on Rule 10b5-1. During the prior three months, Thornton reported sales of 17,775 shares for gross proceeds of $78,032.25 on August 17, 2026, and 4,591 shares for gross proceeds of $21,485.88 on October 15, 2026.
Key Figures
Key Terms
Restricted Stock Units financial
sell to cover financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What CLOV sales did Joseph Clay Thornton report in the prior three months?
What Rule 10b5-1 date does CLOV’s notice list?
AI-generated analysis. How Rhea-AI works. Not financial advice.